Cytek Biosciences (NASDAQ:CTKB) Cut to “Hold” at TD Cowen
TD Cowen cut shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) from a buy rating to a hold rating in a report issued on Friday morning, MarketBeat reports. They currently have $4.00 price objective on the stock. CTKB has been the subject of a number of other research reports. Piper Sandler lowered their target price […]
TD Cowen cut shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) from a buy rating to a hold rating in a report issued on Friday morning, MarketBeat reports. They currently have $4.00 price objective on the stock. CTKB has been the subject of a number of other research reports. Piper Sandler lowered their target price […]
